desglymidodrine

structure in first source

Networked: 3 relevant articles (0 outcomes, 1 trials/studies)

1.	Al-Garem, Nouman: 2 articles (02/2016 - 10/2014)
2.	Ali, Ahmed: 2 articles (02/2016 - 10/2014)
3.	Amin, Mona: 2 articles (02/2016 - 10/2014)
4.	Farid, Samar: 2 articles (02/2016 - 10/2014)
5.	Kassem, Mohamed: 2 articles (02/2016 - 10/2014)
6.	Al-Ghobashy, Medhat: 1 article (02/2016)
7.	Champlain, Jacques de: 1 article (09/2008)
8.	Lamarre-Cliche, Maxime: 1 article (09/2008)
9.	Larochelle, Pierre: 1 article (09/2008)
10.	Souich, Patrick du: 1 article (09/2008)

1.	Ascites 02/01/2016 - "The objective of the present work was to study the clinical pharmacokinetic parameters of midodrine and its active metabolite desglymidodrine in cirrhotic patients with tense ascites, which may help in dose selection and improve treatment outcome. " 02/01/2016 - "Comparative Clinical Pharmacokinetics of Midodrine and Its Active Metabolite Desglymidodrine in Cirrhotic Patients with Tense Ascites Versus Healthy Volunteers." 02/01/2016 - "Midodrine is an α-agonist prodrug of desglymidodrine used for the management of hypotension, and can also be used for hepatorenal syndrome and cirrhotic patients with tense ascites. "
2.	Hypotension (Low Blood Pressure) 10/01/2014 - "Midodrine is an α-agonist prodrug of desglymidodrine used for the management of hypotension. " 02/01/2016 - "Midodrine is an α-agonist prodrug of desglymidodrine used for the management of hypotension, and can also be used for hepatorenal syndrome and cirrhotic patients with tense ascites. "
3.	Vasovagal Syncope 09/01/2008 - "Midodrine is an alpha-agonist prodrug of desglymidodrine (DGM) that has been reported to be of clinical benefit in patients with neurocardiogenic syncope. "
4.	Hepatorenal Syndrome 02/01/2016 - "Midodrine is an α-agonist prodrug of desglymidodrine used for the management of hypotension, and can also be used for hepatorenal syndrome and cirrhotic patients with tense ascites. "